FDA clears two AI tools: pulmonary hypertension detection from ECGs and sepsis prediction
Tempus received FDA clearance for an AI product that flags signs of pulmonary hypertension from standard ECG recordings (24 August). According to CNN, a new FDA-cleared AI system could save thousands of patients who die from sepsis.
Who is affected and how
- doctor
- New early-warning tools are becoming available based on routine tests (ECG) and clinical data.
- hospital manager
- Deploying sepsis prediction brings measurable outcomes as well as an alert burden.
- medtech company
- Cleared examples provide a reference for AI-based early-warning products.
Sources
- Tempus Receives FDA Clearance for its AI Product Intended to Detect Signs of Pulmonary Hypertension From Standard ECGs - BioSpacebiospace.com · Aug 24, 2026
- FDA Clears Tempus AI Tool to Flag Pulmonary Hypertensionmpo-mag.com · Aug 24, 2026
- How a new FDA cleared AI system could save thousands of lives lost to sepsis | CNNcnn.com · Aug 26, 2026
- CNN: How a new FDA cleared AI system could save thousands of lives lost to sepsis - Data Science and AI Instituteai.jhu.edu · Aug 27, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.